secwatch / observer
8-K filed March 13, 2025, 7:59 PM ET ticker AVBP CIK 0001868279
other material confidence high sentiment neutral materiality 0.30

ArriVent BioPharma, Inc. (AVBP): auditor change — ArriVent BioPharma dismisses KPMG, appoints PwC as new auditor

ArriVent BioPharma, Inc.

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.95

ArriVent BioPharma, Inc. engaged PricewaterhouseCoopers LLP as its auditor.

Action
engagement
Auditor
PricewaterhouseCoopers LLP
Exact text from the filing
On March 11, 2025, the Audit Committee appointed PricewaterhouseCoopers LLP (“PwC”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025.
View on SEC.gov
Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.95

ArriVent BioPharma, Inc. dismissed KPMG LLP as its auditor.

Action
dismissal
Auditor
KPMG LLP
Successor
PricewaterhouseCoopers LLP
Exact text from the filing
On March 11, 2025, the Audit Committee (the “Audit Committee”) of the Board of Directors of ArriVent BioPharma, Inc. (the “Company”) approved the dismissal of KPMG LLP (“KPMG”) as the Company’s independent registered public accounting firm.
View on SEC.gov

46 auditor changes filed in the last 30 days. Browse all auditor changes →

ArriVent BioPharma, Inc. filing history →

Source: SEC EDGAR
accession 0001558370-25-002912
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.